您当前的位置: 首页 > 资源详情

Medicalxpress,11月15日,COVID patients on SSRI antidepressants are less likely to die, study finds

编译者:YUTING发布时间:Nov 21, 2021点击量:45 来源栏目:最新研究

A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group.

The results add to a body of evidence indicating that SSRIs may have beneficial effects against the worst symptoms of COVID-19, although large randomized clinical trials are needed to prove this.

"We can't tell if the drugs are causing these effects, but the statistical analysis is showing significant association," said Marina Sirota, Ph.D., associate professor of pediatrics and a member of the Bakar Computational Health Sciences Institute (BCHSI) at UC San Francisco. "There's power in the numbers."

The UCSF-Stanford research team analyzed electronic health records from the Cerner Real World COVID-19 de-identified database, which had information from almost 500,000 patients across the U.S. This included 83,584 adult patients diagnosed with COVID-19 between January and September, 2020. Of those, 3,401 patients were prescribed SSRIs.

The large size of the dataset enabled researchers to compare the outcomes of patients with COVID-19 on SSRIs to a matched set of patients with COVID-19 who were not taking them, thus teasing out the effects of age, sex, race, ethnicity, and comorbidities associated with severe COVID-19, such as diabetes and heart disease, as well as the other medications the patients were taking.

The results showed that patients taking fluoxetine were 28 percent less likely to die; those taking either fluoxetine or another SSRI called fluvoxamine were 26 percent less likely to die; and the entire group of patients taking any kind of SSRI was 8 percent less likely to die than the matched patient controls.

Though the effects are smaller than those found in recent clinical trials of new antivirals developed by Pfizer and Merck, the researchers said more treatment options are still needed to help bring the pandemic to an end.

"The results are encouraging," said Tomiko Oskotsky, MD, a research scientist in Sirota's lab at BCHSI. "It's important to find as many options as possible for treating any condition. A particular drug or treatment may not work or be well tolerated by everyone. Data from electronic medical records allow us to quickly look into existing drugs that could be repurposed for treating COVID-19 or other conditions."

提供服务:导出本资源
  1. 1 Nature,11月10日,Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
  2. 2 11月10日_研究人员分析宿主基因对COVID-19严重程度和易感性的影响
  3. 3 11月11日_新冠药物Remestemcel-L二期临床的中期分析结果积极
  4. 4 11月11日_CDC呼吁制定通用口罩规定以减少新冠传播
  5. 5 SSRN,2月20日,Dynamics of the Latest 2019 Novel Coronavirus Disease Epidemic in China: A Descriptive Study
  6. 6 SSRN,2月20日,Mental Health Problems and Social Media Exposure During COVID-19 Outbreak
  7. 7 SSRN,2月20日,Evaluating Incidence and Impact Estimates of the Coronavirus Outbreak from Official and Non-Official Chinese Data Sources
  8. 8 SSRN,2月20日,Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China
  9. 9 Nature,11月10日,Mobility network models of COVID-19 explain inequities and inform reopening
  10. 10 1月27日_Nature报道中国新型冠状病毒最新研究进展:病毒传播速度有多快?
  1. 1 Medicalxpress,1月13日,Preliminary research suggests SARS-CoV-2 virus less infectious within five minutes of exposure to air
  2. 2 Medicalxpress,1月13日,Maternal COVID-19 infection increases risks of preterm birth, low birth weight and stillbirth
  3. 3 Medicalxpress,1月12日,Researchers use artificial intelligence to guide the search for the next SARS-like virus
  4. 4 1月12日_研究人员发现可抑制SARS-CoV-2复制的化合物
  5. 5 1月12日_全球研究揭示儿童严重COVID-19相关风险因素
  6. 6 Phys.org,1月11日,Catching the COVID wiggle: Researchers develop new way to visualize how the spike protein shows off its moves
  7. 7 Homeland Preparedness News,1月11日,FDA shortens wait time for Moderna COVID-19 booster vaccine to five months
  8. 8 1月10日_辉瑞COVID-19疫苗预防炎症综合征的有效性为91%
  9. 9 Medicalxpress,1月10日,Even symptom-free, people with Omicron are much more likely to spread COVID, say studies
  10. 10 Medicalxpress,1月10日,Researchers use artificial intelligence to guide the search for the next SARS-like virus

版权所有@2017中国科学院文献情报中心

制作维护:中国科学院文献情报中心信息系统部地址:北京中关村北四环西路33号邮政编号:100190